Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03872141
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:11.644747+00:00
Published At
2021-05-03T00:00:00+00:00
Record Updated At
2021-05-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Breast Cancer", "Chemotherapy Induced Peripheral Neuropathy", "Paclitaxel Induced Neuropathy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-05-03"
protocolSection.identificationModule.nctId
"NCT03872141"
protocolSection.identificationModule.officialTitle
"Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Breast Cancer (protocolSection.conditionsModule.conditions)
  • Chemotherapy Induced Peripheral Neuropathy (protocolSection.conditionsModule.conditions)
  • Paclitaxel Induced Neuropathy (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.